Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company's stock reacted negatively in ...

Erin Wright, an analyst from Morgan Stanley, assigned the Buy rating on Cigna (CI – Research Report). The associated price target is ...

Barclays analyst Andrew Mok lowered the firm’s price target on Cigna (CI) to $339 from $420 and keeps an Overweight rating on the shares post ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Wall Street opens up on relief Meta and Microsoft kept their AI spending plans even as their earnings come in mixed. Next up, Apple after the close.

Shares of Cigna Group slid after the health insurer warned that higher health-care costs in one insurance unit weighed on profitability. Insurers saw profit margins soar in the pandemic as insurees ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Cigna Group closed 23.69% below its 52-week high of $370.83, which the company reached on September 16th.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Shares of Cigna ( CI -8.00%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% ...

Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...